Amgen Inc. buy Piper Jaffray Companies
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
8.92%
End price
03.01.26
€277.20
Summary
This prediction ended on 03.01.26 with a price of €277.20. With a performance of 8.92%, the BUY prediction by Piper_Jaffray_Compan for Amgen Inc. closed with a slight gain. A total of €9.41 was paid as dividends for this prediction. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -0.244% | -0.244% | 7.554% |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $310.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten